Keyphrases
Adult Patients
100%
Fontan Procedure
100%
Exercise Capacity
100%
Ambrisentan
100%
Placebo
60%
Fontan Patients
60%
Short Form 36 (SF-36)
40%
Pulmonary Vascular Resistance
40%
Patient-completed
20%
Randomized Double-blind
20%
Placebo-controlled
20%
Renal Function
20%
Quality of Life
20%
Maximal Oxygen Uptake
20%
Physical Function
20%
Single Center
20%
Ventricle
20%
Liver Function
20%
Endothelin Receptor Antagonist
20%
36-item Short Form
20%
Function Score
20%
Cardiopulmonary Exercise Testing
20%
Ventilatory Equivalent
20%
Physiological Deterioration
20%
Respiratory Exchange Ratio
20%
Endothelin Receptor Antagonism
20%
Medicine and Dentistry
Fontan Procedure
100%
Ambrisentan
100%
Placebo
80%
Deterioration
40%
Short Form 36
40%
Lung Vascular Resistance
40%
Oxygen Consumption
20%
Kidney Function
20%
Quality of Life
20%
Ventricle of Heart
20%
Lung Gas Exchange
20%
Endothelin Receptor Antagonist
20%
Liver Function
20%
Cardiopulmonary Exercise Test
20%
Endothelin Receptor
20%
Side Effect
20%
Pharmacology, Toxicology and Pharmaceutical Science
Ambrisentan
100%
Placebo
80%
Deterioration
40%
Endothelin Receptor Antagonist
20%
Endothelin Receptor
20%
Side Effect
20%